U
Utah Medical Products, Inc. (UTMD)
NMS – Real Time Price. Currency in USD
63.82
-0.18 (-0.28%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
63.82
-0.18 (-0.28%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 28.64 | 3.39 | 10 | |
| Quick ratio | 26.15 | 2.51 | 10 | |
| Debt to Equity | 0.00 | 0.29 | 10 | |
| Debt to Assets | 0.00 | 0.62 | 10 | |
| Interest coverage | N/A | 24.85 | 10 | |
| Weighted average score | 10 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 52M | 50M | 41M | 39M | 38M |
| Gross Profit | 26M | 24M | 22M | 20M | 20M |
| Operating Income | 20M | 18M | 16M | 13M | 11M |
| Net Income | 16M | 17M | 14M | 11M | 11M |
| EBITDA | 28M | 25M | 19M | 16M | 11M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -3.56 | 1.48 | N/A | N/A | 1.5 |
| Y/Y | -10.17 | -14.36 | N/A | N/A | 1.0 |
| 3y average | -9.42 | -11.41 | N/A | -9.33 | 1.0 |
| 5y average | -1.07 | 2.82 | N/A | -4.47 | 1.8 |
| Weighted average score | 1.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 2.02 | 2.02 | 7.0 |
| Payout ratio | 21.22 | 21.22 | 4.0 |
| 5-year dividend growth rate | 1.63 | 1.63 | 3.0 |
| Years of dividend increase | 3.00 | 3.00 | 3.0 |
| Weighted average score | 4.3 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $0.0 barely cover the upcoming debt maturities $210.0K
Total current assets $100.4M exceed Total current liabilities $3.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength